Gebro Pharma Arosuva plus Ezetimib

Arosuva plus Ezetimib is a prescription-only combination medication used to treat high cholesterol levels and reduce the risk of cardiovascular disease. It contains two active ingredients: Rosuvastatin (a statin) and Ezetimibe (a cholesterol absorption inhibitor). The product is manufactured and distributed by Gebro Pharma GmbH, a family-owned pharmaceutical company based in Austria.

Gebro Pharma was founded in 1947 in Fieberbrunn, Tyrol, where its central production and research facilities remain located. The company is an independent Austrian enterprise that develops, produces, and markets its own pharmaceuticals and distributes products for international partners. In the context of global pharmaceutical ownership for 2026 and beyond, Gebro Pharma remains a privately held entity, firmly rooted in its Austrian origin without being absorbed by larger multinational conglomerates.